Chen, L.; Mu, W.; Gu, J.; Xiao, M.; Huang, L.; Zheng, M.; Li, C.; Xiao, Y.; Zhou, J.; Long, X.
TP53-Mutated Circulating Tumor DNA for Disease Monitoring in Lymphoma Patients after CAR T Cell Therapy. Diagnostics 2021, 11, 844.
https://doi.org/10.3390/diagnostics11050844
AMA Style
Chen L, Mu W, Gu J, Xiao M, Huang L, Zheng M, Li C, Xiao Y, Zhou J, Long X.
TP53-Mutated Circulating Tumor DNA for Disease Monitoring in Lymphoma Patients after CAR T Cell Therapy. Diagnostics. 2021; 11(5):844.
https://doi.org/10.3390/diagnostics11050844
Chicago/Turabian Style
Chen, Liting, Wei Mu, Jia Gu, Min Xiao, Liang Huang, Miao Zheng, Chunrui Li, Yi Xiao, Jianfeng Zhou, and Xiaolu Long.
2021. "TP53-Mutated Circulating Tumor DNA for Disease Monitoring in Lymphoma Patients after CAR T Cell Therapy" Diagnostics 11, no. 5: 844.
https://doi.org/10.3390/diagnostics11050844
APA Style
Chen, L., Mu, W., Gu, J., Xiao, M., Huang, L., Zheng, M., Li, C., Xiao, Y., Zhou, J., & Long, X.
(2021). TP53-Mutated Circulating Tumor DNA for Disease Monitoring in Lymphoma Patients after CAR T Cell Therapy. Diagnostics, 11(5), 844.
https://doi.org/10.3390/diagnostics11050844